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Abstract Rinsing bone grafts before or both before and after 
impaction might have different effects on the incorporation of 
the graft. Rinsing again after impaction might negatively 
influence bone induction if growth factors released by 
impaction are washed away. We studied if transforming 
growth factor-|3s (TGF-|3s) and bone morphogenetic proteins 
(BMPs) are released from the mineralised matrix by 
impaction and if these released growth factors induce 
osteogenic differentiation in human mesenchymal stem cells 
(hMSCs). Rinsed morsellised bone allografts were impacted 
in a cylinder and the escaping fluid was collected. The fluid 
was analysed for the presence of TGF-|3s and BMPs, and the 
osteoinductive capacity was tested on hMSCs. Abundant 
TGF-|3 was present in the fluid. No BMPs could be detected. 
Osteogenic differentiation of hMSCs was inhibited by the 
fluid. Results from our study leave us only able to speculate 
whether rinsing grafts again after impaction has a beneficial 
effect on the incorporation process or not.
Résumé Laver les greffons avant et après impaction peut 
avoir des conséquences diverses sur l’incorporation de la
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greffe. En effet, laver à nouveau après l’impaction aura une 
influence négative sur l’induction osseuse car les facteurs 
de croissances relargués par l’impaction ont été éliminés. 
Nous avons étudié ainsi le facteur TGF-|3s et BMPs 
relargués de la matrice minérale osseuse après impaction 
et si ce relarguage des facteurs avaient une action 
d’ induction ostéogénique sur la différenciation des cellules 
mésenchymateuses hMSCs. Pour cela, nous avons lavé 
l’allogreffe quand celle-ci est impactée dans un cylindre et 
que les fluides ont été collectés. Les fluides sont analysés 
pour détecter la présence de TGF-|3s et BMPSs et, les 
capacités d’ostéo induction sont testées sur des cellules 
mésenchymateuses humaines. Une quantité abondante de 
TGF-|3s se retrouve dans les fluides, par contre nous n ’avons 
pas retrouvé de BMPs. La différenciation ostéogénique sur 
les cellules mésenchymateuses hMSCs est inhibée par ce 
fluide. Les résultats de ce travail nous permettent de penser 
que l ’action de laver les greffons après impaction peut avoir 
un effet bénéfique ou non sur l ’incorporation.
Introduction
Bone impaction grafting with a cemented prostheses is a 
biologically attractive technique for treating bone stock 
defects around failed total hip prostheses, with long-term 
clinical survival data available both on the acetabular and 
the femoral sides [8, 21].
Although the technique on the acetabular side has been 
well described by the original promoters [22], a dispute has 
been raised about the pros and cons of rinsing the allograft 
bone chips. Both rinsing once (before) and twice (before 
and after) impaction are used. However, rinsing before 
impaction or before and after impaction might have quite 
different effects on the incorporation of the grafts.
Ô  Springer
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Rinsing before impaction enhances the stability of graft 
reconstructions by creating a higher interparticle shear 
resistance [7]. Also, in more realistic acetabular testing 
models with bone impaction grafting, rinsing had a positive 
effect on the initial stability of the cemented cups [1, 25]. In 
addition, the use of allografts induces an immunogenic 
response to the graft. Since most antigenic cells are found 
in the marrow, rinsing the grafts to remove blood, marrow 
and fat have been shown to diminish this negative aspect 
[10]. Bone grafts rinsed before impaction are better 
incorporated compared to unrinsed allografts [27].
Rinsing again after impaction is performed, however, 
only on the acetabular side, in the expectation of an 
additional effect on the initial mechanical stability through 
an increase in cement penetration. Although clinically 
practised, there is no experimental data supporting the 
benefit of rinsing again after impaction. It is not known 
how the rinsing of morsellised bone grafts again after 
impaction affects the incorporation process. Rinsing the 
grafts again after impaction might have a negative effect on 
bone induction if growth factors released by impaction are 
washed away.
By the impaction procedure, many microfractures are 
created, and biologically active factors in the bone matrix 
are, consequently, released. Recently, it was shown that a 
physiologically significant amount of transforming growth 
factor-|3 (TGF-|3) was released by the strong compression 
of rinsed cancellous bone blocks from femoral heads [9]. 
Many contradictory reports have been published on the 
effects of TGF-|3s on bone formation [2, 12], however, the 
effects of TGF-|3s on bone graft incorporation are 
unknown.
Furthermore, it is not known if, other, more potent 
stimulators of bone induction, like bone morphogenetic 
proteins (BMPs), are released in physiologically relevant 
concentrations from the mineralised matrix during impac­
tion. Therefore, we studied if TGF-|3s and BMPs are 
released in physiologically relevant concentrations from the 
mineralised bone matrix by firm impaction, and if these 
released growth factors induce osteogenic differentiation in 
human mesenchymal stem cells (hMSCs).
Materials and methods
Production of “impaction fluid”
Cancellous allografts were collected from five human 
femoral heads obtained from the authors’ institutional bone 
bank. Swabs were taken and tested for bacterial contami­
nation. All specimens were clear of bacterial contamination. 
The allografts were cut to 5x5x5-mm pieces using a 
rongeur and were subsequently pooled. Blood and marrow
were removed macroscopically by rinsing the grafts with 
saline for approximately 1 min, leaving only a white bone 
structure. Rinsing was done using a commercially available 
high-pressure pulsatile lavage system (SurgiLav® Plus, 
Stryker Nederland BV, Waardenburg, the Netherlands). 
The grafts were in a sieve during rinsing. Allografts were 
dried overnight in a laminar flow cabinet (sterile airflow) at 
4°C.
The bone grafts were inserted into a cylinder with a 
diameter of 30 mm. A piston, slightly smaller in diameter, 
was inserted into this cylinder. A rubber ring, sealing the 
piston, prevented the escape of fluid between the piston and 
the wall of the cylinder. Using an MTS loading device 
(MTS Systems Corporation, Minneapolis, MN, USA), the 
allografts were impacted. Fluid was evacuated through a 
canal in the bottom of the cylinder and were collected 
sterile. The applied pressure was calculated to be
12.5 MPa. The gathered fluid was centrifuged for 10 min 
at 3,000 rpm at 4°C. Any cellular and fatty debris was 
separated from the supernatant. The supernatant was called 
“impaction fluid.”
Analysis of “impaction fluid”
TGF-|31 and TGF-|32 levels in the “impaction fluid” were 
measured by enzyme-linked immunosorbent assay (ELISA; 
Quantikine®, R&D Systems Europe Ltd., Abingdon, 
United Kingdom) according to the manufacturer’s instruc­
tions. The plate was read in an ELISA reader at 450 nm 
(Sunrise™, Tecan Group Ltd., Mannedorf, Switzerland). 
Experiments were performed in triplicate.
The presence of BMPs was determined using a modified 
BMP-selective reporter bioassay (BRE-luc) inducing lucif- 
erase expression [16]. This assay is based on 3T3 
fibroblasts stably transfected with the BRE-luc reporter 
construct. In short, 3T3 BRE-luc cells were seeded in a 
density of 20,000 per well in microtitre plates in D-MEM 
(Gibco Invitrogen Corp., Grand Island, NY, USA) with 5% 
FCS. After 24 h, BMP-containing samples were added and 
the cells were incubated for a further 20 h. Luciferase 
activity was quantified using the Bright-Glo™ Luciferase 
Assay System (Promega, Madison, WI, USA). Lumines­
cence was measured using a plate luminometer according to 
the manufacturer’s protocol (POLARstar Galaxy, BMG 
Labtech GmbH, Offenburg, Germany). For the standard 
curve, serial dilutions of rhBMP-2 (R&D Systems Europe 
Ltd., Abingdon, United Kingdom) to final concentrations of
0 to 100 ng BMP-2/ml were used. The lower detection limit 
of this assay is 1.6 ng/ml BMP-2. Experiments were 
performed in triplicate.
Almost all members of the TGF-|3 family, including 
BMPs, are secreted as latent complexes and need to be 
activated to exhibit their biological activity [28]. Therefore,
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International Orthopaedics (SICOT) (2009) 33:861-866 863
both active and total growth factor levels were measured in 
order to have an impression of latent growth factor levels. 
The total growth factor levels were measured by activating 
the growth factors in the samples using hydrochloric acid 
and, subsequently, neutralising the samples by sodium 
hydroxide, according to the manufacturer’s instructions.
Culture study
Human mesenchymal stem cells (Poietics™ hMSC, Cambrex 
Bio Science Verviers, S.p.r.l., Belgium) were cultured up to 
passage 7 on mesenchymal stem cell growth medium 
(MSCGM™ BulletKit® (PT-3001), Cambrex Bio Science 
Verviers, S.p.r.l., Belgium). The cells were incubated in a 
humidified atmosphere of 92.5% air and 7.5% CO2 at 37°C. 
After primary culture, cells were detached using trypsin/ 
EDTA (Cambrex Bio Science Verviers, S.p.r.l., Belgium), 
and the cells were seeded in 96-well plates at a density of 
20,000 cells/cm2. The cells were allowed to attach overnight. 
After cell attachment, the cells were cultured under static 
conditions for 7 days. Cells were cultured on osteogenic 
differentiation medium (hMSC Osteogenic Differentiation 
BulletKit® (PT-3002), Cambrex Bio Science Verviers, S.p.r. 
l., Belgium) with and without 10-7 M dexamethasone 
(Sigma, Chemical Co., St. Louis, MO, USA). The superna­
tant (“impaction fluid”) was lyophilised. Subsequently, the 
lyophilised “impaction fluid” was resuspended in osteogenic 
differentiation medium (without dexamethasone), equal to 
the original volume of the supernatant. The hMSCs were 
stimulated with 5 ng/ml TGF-|31 (rhTGF-|31, R&D Systems 
Europe Ltd., Abingdon, United Kingdom), 10 8 M vitamin 
D3 [1,25(OH)2D3], 100 ng/ml BMP-2 (rhBMP-2, R&D 
Systems Europe Ltd., Abingdon, United Kingdom) and 
10%, 20%, 40% and 80% “impaction fluid.” The culture 
medium was changed every three days. Experiments were 
performed in triplicate. Osteogenic differentiation medium 
without dexamethasone was used as the negative control, 
whereas osteogenic differentiation medium supplemented 
with dexamethasone and vitamin D3 was used as the 
positive control [4].
Alkaline phosphatase assay
Alkaline phosphatase (ALP) activity was measured to 
obtain information about the osteogenic differentiation of 
the cells. Medium was removed and the cell layers were 
washed twice with phosphate buffer solution (PBS). The 
cells were fixed with 4% buffered formaldehyde and 
washed twice with PBS again.
The substrate solution was made by adding 1 ml of 
10 mM MgCl2 to 10 ml of 1 M di-ethanol-amine (DEA) 
and dissolving 52.6 mg of para-nitrophenyl phosphate 
(PNPP) in 10 ml of this solution. Subsequently, 100 |o.l of
substrate solution was added to each well and the plate was 
incubated for 15 min. The reaction was stopped by adding 
100 |o.l of 0.5 M NaOH. The plate was read in an ELISA 
reader at 405 nm (Wallac™ VICTOR2 1420, PerkinElmer 
Life and Analytical Sciences, Inc., Boston, MA, USA).
Neutral red assay
A neutral red (NR) assay was performed to obtain an 
indication of the number of viable cells (proliferation). A 
1:1 solution of neutral red stock (1 mg/ml milliQ water) and 
1.8% NaCl solution was made and filtered. One hundred 
microlitres (100 |o.l) of this solution was added to each well 
and the plate was incubated for 90 min at 37°C. Neutral red 
solution was removed and the cell layers were washed 
twice with PBS. Subsequently, 100 .^l of elution buffer 
(0.05 M NaH2PO4/50% EtOH) was added to each well. The 
plate was read in an ELISA reader at 550 nm (Wallac™ 
VICTOR2 1420, PerkinElmer Life and Analytical Sciences 
Inc., Boston, MA, USA). The neutral red assay was used to 
correct the alkaline phosphatase assay for the number of 
viable cells.
Results
Analysis of “impaction fluid”
Analysis of the “impaction fluid” revealed that TGF-|3 was 
abundant. Both TGF-|31 and TGF-|32 were present in the 
“impaction fluid” in physiologically significant amounts. The 
total levels of TGF-|31 and TGF-|32 present after activation 
were 5.39 (±1.12) ng/g bone and 1.20 (±0.12) ng/g bone, 
respectively. Before the samples were activated, an already 
active amount of 0.43 (±0.05) ng TGF-|31/g bone and 0.13 
(±0.11) ng TGF-|32/g bone was measured (Fig. 1). No BMPs 
could be detected using the BMP-selective reporter bioassay. 
Luciferase expression did not exceed the detection limit of 
1.6 ng BMP-2/ml.
Cell culture study
Adding dexamethasone to the osteogenic differentiation 
medium caused an approximately three-fold increase in 
ALP activity. Vitamin D3 added to osteogenic differentia­
tion medium supplemented with dexamethasone showed 
the highest induction of ALP activity, whereas the addition 
of 5 ng/ml TGF-|31 strongly suppressed the induction of 
ALP activity. The “impaction fluid” dose-dependently 
suppressed the ALP activity induced by dexamethasone 
(Fig. 2). Both 40% and 80% “impaction fluid” showed 
similar suppression to 5 ng/ml TGF-|31.
^  Springer
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Fig. 1 Level of transforming growth factor-|31 and -p2 (TGF-|31 and 
TGF-|32) measured in the “impaction fluid.” Both total and already 
active growth factor levels are shown. Data are mean±standard 
deviation (SD) of experiments performed in triplo
Discussion
The fracture surface created by impaction could have a 
growth-promoting effect by enabling the release of growth 
factors. Rinsing morsellised bone grafts again after impac­
tion, therefore, might have a negative effect on bone 
induction if growth factors released during impaction are 
washed out. In our study, we examined if TGF-|3 and 
BMPs are released from the mineralised matrix by 
impaction, and whether these released growth factors 
induce osteogenic differentiation in hMSCs.
Both TGF-|31 and TGF-|32 were abundantly present in 
“impaction fluid.” Corresponding to what is seen in 
demineralised bone, in our study, most TGF-|3 was present 
in a latent form. Bone grafts from five femoral heads were 
pooled to minimise variation to overcome possible bias. 
However, it should be noticed that a large variation of TGF- 
|3 exists in human bone tissue both in tissue location and 
between individuals [19]. Our results are in accordance
with the results of Fyhrie et al. [9] who recently showed 
that strong mechanical compression of cancellous bone 
blocks from femoral heads accelerates the release of TGF- 
|32. In addition, they and others suggested that mechanical 
loading also might accelerate the release of other growth 
factors, like BMPs, from mineralised bone matrix [3, 9]. In 
our study, however, no BMPs could be detected. In the light 
of the overwhelming literature on BMPs in bone [23, 24], 
we have to conclude from this experiment that BMPs 
cannot be released from the mineralised matrix by 
impaction. The BMPs in bone are considered to be 
activated by demineralisation [26]; however, as described 
in Burwell’s classical work on bone grafting, some new 
bone formation may be induced also from non-demineral- 
ised allografts [5]. If all BMPs are retained in the bone, this 
might explain the coupling of resorption and new bone 
formation during the incorporation of morsellised cancel­
lous bone in bone impaction grafting [20].
Since TGF-|3 is abundantly present in the “impaction 
fluid,” it is not surprising to see a suppression of osteogenic 
differentiation with an increasing concentration of “impac­
tion fluid” in our culture experiment. TGF-|3 is known to 
inhibit the ALP expression of mesenchymal stem cells 
(MSCs), even when these cells are stimulated with BMPs 
[12, 17]. In contrast to BMPs, TGF-|3 is unable to induce 
osteogenesis in mesenchymal pluripotent cells [12, 14]. 
From this perspective, it seems that rinsing bone grafts 
again after impaction might even be beneficial if TGF-|3 is 
washed away.
Data from numerous in vitro experiments have demon­
strated the role of TGF-|3 in every stage of bone formation [6, 
12]. Despite conflicting results, most data support the 
following model [12]: TGF-|3 increases bone formation in 
vitro mainly by recruiting osteoblast progenitors and 
stimulating their proliferation, thus, expanding the pool of 
committed osteoblasts, in addition to promoting the early 
stages of differentiation (bone matrix production). On the
Fig. 2 Data from cell culture. 
Human mesenchymal stem cells 
(hMSCs) were cultured with and 
without dexamethasone. As a 
measure for osteogenic differ­
entiation, alkaline phosphatase 
activity (ALP) was corrected for 
the number of viable cells (NR). 
Data are mean±SD of experi­
ments performed in triplicate
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other hand, it blocks later phases of differentiation and 
mineralisation. These later stages are regulated by other 
growth factors, like BMPs. In other words, TGF-|3 generally 
inhibits the mineralisation of the matrix it helps to produce.
However, TGF-|3 not only modulates bone formation, but 
it can also stimulate osteoclast recruitment, formation and 
function [11, 15]. Bone resorption is more detrimental for the 
outcome of impaction grafting than just suppression or lack 
of bone formation, because resorption may compromise 
implant fixation [13, 18]. In addition, little or no BMPs from 
bone can be released prior to demineralisation. Only 
biological remodelling might free these factors (BMPs) to 
stimulate bone formation. Therefore, removing the excess of 
TGF-|3 from bone grafts might be a useful procedure.
On the contrary, TGF-|3 released after impaction might, 
indeed, be beneficial at an early stage postoperatively when 
chemotactic and proliferative signals might be needed. 
Furthermore, TGF-|3 promotes the early stages of osteoblast 
differentiation. However, the fluid released by the impac­
tion procedure in clinical surgery will, probably, only be in 
situ for a short period of time at the very early postoperative 
stage, when osteoblast differentiation is not relevant.
It should be noticed that results obtained in vitro are often 
not in line or even contradictory to in vivo observations. In 
vivo, the presence of other growth factors, cytokines and 
hormones in the bone environment and the environment 
itself determine the exact outcome of TGF-|3 function.
In summary, by rinsing morsellised bone grafts again 
after impaction, growth factors (TGF-|3s) released during 
impaction are washed out. Although TGF-|3 appears to be 
a potent stimulator of chemotaxis and the proliferation of 
osteoblasts, but also of osteoclast recruitment, formation 
and bone resorption, more potent stimulators of bone 
formation (BMPs) are not released from a mineralised 
matrix during impaction. To our knowledge, there is only 
one study reporting in vivo data on the effects of rinsing 
and the impaction of morsellised bone grafts on bone 
ingrowth [27]. Rinsing before impaction increased bone 
ingrowth in the allograft group to approach that of 
autografts. However, rinsing after impaction did not 
additionally alter bone ingrowth. The results from our 
study, and the dual effects of TGF-|3 reported in the 
literature, leave us only able to speculate whether rinsing 
grafts again after impaction has a beneficial effect on the 
incorporation process.
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